Logo image of LXEH

LIXIANG EDUCATION HOLDIN-ADR (LXEH) Stock Fundamental Analysis

NASDAQ:LXEH - Nasdaq - US53934A2069 - ADR - Currency: USD

1.838  -0.02 (-1.18%)

After market: 1.82 -0.02 (-0.98%)

Fundamental Rating

2

Taking everything into account, LXEH scores 2 out of 10 in our fundamental rating. LXEH was compared to 70 industry peers in the Diversified Consumer Services industry. LXEH has a bad profitability rating. Also its financial health evaluation is rather negative. LXEH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

LXEH had negative earnings in the past year.
LXEH had a negative operating cash flow in the past year.
LXEH had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: LXEH reported negative operating cash flow in multiple years.
LXEH Yearly Net Income VS EBIT VS OCF VS FCFLXEH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

LXEH has a Return On Assets of -5.21%. This is comparable to the rest of the industry: LXEH outperforms 47.14% of its industry peers.
LXEH has a Return On Equity of -16.82%. This is comparable to the rest of the industry: LXEH outperforms 44.29% of its industry peers.
Industry RankSector Rank
ROA -5.21%
ROE -16.82%
ROIC N/A
ROA(3y)-11.95%
ROA(5y)-15.39%
ROE(3y)-33.7%
ROE(5y)-59.35%
ROIC(3y)N/A
ROIC(5y)N/A
LXEH Yearly ROA, ROE, ROICLXEH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LXEH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LXEH Yearly Profit, Operating, Gross MarginsLXEH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

3

2. Health

2.1 Basic Checks

LXEH does not have a ROIC to compare to the WACC, probably because it is not profitable.
LXEH has a worse debt/assets ratio than last year.
LXEH Yearly Shares OutstandingLXEH Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K 1M
LXEH Yearly Total Debt VS Total AssetsLXEH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of -0.40, we must say that LXEH is in the distress zone and has some risk of bankruptcy.
LXEH has a worse Altman-Z score (-0.40) than 64.29% of its industry peers.
A Debt/Equity ratio of 0.58 indicates that LXEH is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.58, LXEH is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Altman-Z -0.4
ROIC/WACCN/A
WACC2.98%
LXEH Yearly LT Debt VS Equity VS FCFLXEH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 2.09 indicates that LXEH has no problem at all paying its short term obligations.
The Current ratio of LXEH (2.09) is better than 75.71% of its industry peers.
A Quick Ratio of 2.09 indicates that LXEH has no problem at all paying its short term obligations.
LXEH's Quick ratio of 2.09 is fine compared to the rest of the industry. LXEH outperforms 75.71% of its industry peers.
Industry RankSector Rank
Current Ratio 2.09
Quick Ratio 2.09
LXEH Yearly Current Assets VS Current LiabilitesLXEH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2

3. Growth

3.1 Past

LXEH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.62%, which is quite impressive.
Looking at the last year, LXEH shows a very negative growth in Revenue. The Revenue has decreased by -37.25% in the last year.
LXEH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.69% yearly.
EPS 1Y (TTM)98.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.07%
Revenue 1Y (TTM)-37.25%
Revenue growth 3Y-1.41%
Revenue growth 5Y19.69%
Sales Q2Q%-32%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LXEH Yearly Revenue VS EstimatesLXEH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 50M 100M

0

4. Valuation

4.1 Price/Earnings Ratio

LXEH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LXEH Price Earnings VS Forward Price EarningsLXEH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LXEH Per share dataLXEH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

LXEH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LIXIANG EDUCATION HOLDIN-ADR

NASDAQ:LXEH (6/20/2025, 8:00:00 PM)

After market: 1.82 -0.02 (-0.98%)

1.838

-0.02 (-1.18%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)N/A N/A
Earnings (Next)01-06 2022-01-06
Inst Owners0.79%
Inst Owner Change1209.98%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.14M
Analysts0
Price TargetN/A
Short Float %0.31%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.48
P/FCF N/A
P/OCF N/A
P/B 0.1
P/tB 0.1
EV/EBITDA N/A
EPS(TTM)-2.93
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.18
FCFYN/A
OCF(TTM)-2.15
OCFYN/A
SpS3.82
BVpS17.53
TBVpS17.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.21%
ROE -16.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-11.95%
ROA(5y)-15.39%
ROE(3y)-33.7%
ROE(5y)-59.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.52%
Cap/Sales 0.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.09
Quick Ratio 2.09
Altman-Z -0.4
F-Score3
WACC2.98%
ROIC/WACCN/A
Cap/Depr(3y)49.61%
Cap/Depr(5y)127.18%
Cap/Sales(3y)6.14%
Cap/Sales(5y)22.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.07%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-37.25%
Revenue growth 3Y-1.41%
Revenue growth 5Y19.69%
Sales Q2Q%-32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y69.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y72.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y69.49%
OCF growth 3YN/A
OCF growth 5YN/A